Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da‐Sol Kuen, Byung‐Seok Kim, Yeonseok Chung
Immune Network (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors
Jang Hyun Park, Hyun-Jin Kim, Chae Won Kim, et al.
Nature Immunology (2021) Vol. 22, Iss. 3, pp. 336-346
Closed Access | Times Cited: 105
MYC targeting by OMO-103 in solid tumors: a phase 1 trial
Elena Garralda, Marie‐Eve Beaulieu, Víctor Moreno, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 762-771
Open Access | Times Cited: 60
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
Erna Marija Meškytė, Sabiha Keskas, Yari Ciribilli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7710-7710
Open Access | Times Cited: 73
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1292-1308
Open Access | Times Cited: 30
The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target
Tewodros Shibabaw, Banchamlak Teferi, Birhanu Ayelign
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression
Yu Wang, Jiazhou Li, Shingo Nakahata, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7346-7346
Open Access | Times Cited: 9
The role of interleukin-17 in inflammation-related cancers
Xingru Zhang, Bin Li, Lü Tian, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Intestinal microbiota: a new force in cancer immunotherapy
Zhujiang Dai, Jingqiu Zhang, Qi Wu, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer
Elena Niccolai, Edda Russo, Simone Baldi, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 52
The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms
Sofía Frigerio, Dalia A. Lartey, Geert R. D’Haens, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12739-12739
Open Access | Times Cited: 45
Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer
Shun Li, Ruisi Na, Xuehan Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188758-188758
Closed Access | Times Cited: 31
Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy
Melissa G. Lechner, Mandy I. Cheng, Anushi Y. Patel, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 4, pp. 696-709
Open Access | Times Cited: 29
The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study
Qiang Cao, Xinyan Wu, Yuquan Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 20
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging
Ayako Kurioka, Paul Klenerman
Seminars in Immunology (2023) Vol. 69, pp. 101816-101816
Open Access | Times Cited: 18
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Robin Reschke, Alexander Enk, Jessica C. Hassel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 7
Traversing through the Mechanistic Event Analysis in IL-6 and IL-17 Signaling for a New Therapeutic Paradigm in NSCLC
Riya Khilwani, Shailza Singh
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1216-1216
Open Access | Times Cited: 6
Discovery of Two Novel Immunoepitopes and Development of a Peptide-based Sarcoidosis Immunoassay
Changya Peng, Jaya Talreja, Brennen Steinbauer, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 7, pp. 908-918
Closed Access | Times Cited: 6
Microbiota as the unifying factor behind the hallmarks of cancer
Iva Benešová, Ľudmila Křížová, Miloslav Kverka
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14429-14450
Open Access | Times Cited: 14
Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC
Kennady K. Bullock, Rebecca L. Shattuck-Brandt, Carly Bess Scalise, et al.
Cancer Letters (2024) Vol. 586, pp. 216681-216681
Open Access | Times Cited: 5
Could Neisseria gonorrhoeae have carcinogenic potential? A critical review of current evidence
Alexander Ngoo, Evgeny A. Semchenko, Anthony Atack, et al.
Critical Reviews in Microbiology (2025), pp. 1-12
Closed Access
La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacy
Karen Slattery, David K. Finlay, Phillip K. Darcy
Immunometabolism (2025) Vol. 7, Iss. 1, pp. e00055-e00055
Open Access
IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathway
Huixiang Zhang, Haohan Li, Yanyan Qi, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114226-114226
Open Access
MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways
Fei Wang, Han Zhang, Xiru Liu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Oral Microbiota from Periodontitis Promote Oral Squamous Cell Carcinoma Development via γδ T Cell Activation
Wei Wei, Jia Li, Xin Shen, et al.
mSystems (2022) Vol. 7, Iss. 5
Open Access | Times Cited: 21
Targeting interleukin-17 in radiation-induced toxicity and cancer progression
Piyush Baindara
Cytokine & Growth Factor Reviews (2024) Vol. 75, pp. 31-39
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top